相关实验视频
Updated: Jun 23, 2026

07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
抗氧化基因治疗心血管疾病:目前的状况和未来的前景
Anna-Liisa Levonen1, Elisa Vähäkangas, Jonna K Koponen
1Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Finland. Anna-Liisa.Levonen@uku.fi
Circulation
|April 23, 2008
概括
抗氧化基因疗法通过对抗过度反应性氧物种,显示出治疗心血管疾病的前景. 本综述探讨了成功的研究,目前的局限性,以及这种治疗方法的未来方向.
科学领域:
- 心血管医学 心血管医学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 过度的活性氧物种 (ROS) 生产与诸如高血压,动脉样硬化和心肌梗塞等心血管病理有关.
- 自然抗氧化剂防御可以被压倒,从而产生治疗干预的需要.
- 抗氧化剂疗法提供了一个潜在的策略,以恢复平衡,当内源防御是不够的.
研究的目的:
- 审查抗氧化剂基因治疗在治疗心血管疾病中的成功应用.
- 确定目前阻碍抗氧化基因疗法的有效性的局限性.
- 为改善治疗结果提出未来的治疗目标和方法上的进步.
主要方法:
- 对利用抗氧化剂基因疗法治疗心血管疾病的研究进行文献综述.
- 分析成功的治疗结果和发现的挑战.
- 探索新兴的治疗目标和创新的方法.
主要成果:
- 抗氧化基因疗法已在各种心血管疾病的临床前和临床环境中取得成功.
- 关键的限制包括输送方法,免疫反应和长期疗效.
- 新兴的策略集中在向基因传递和新型抗氧化剂途径上.
结论:
- 抗氧化基因疗法代表了由氧化应激驱动的心血管疾病的有希望的治疗途径.
- 克服目前的局限性对于广泛的临床采用至关重要.
- 未来的研究应该专注于改进输送系统,并确定新的治疗点,以提高治疗疗效.
相关概念视频
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

